COMMUNIQUÉS West-GlobeNewswire

Erdem Hospital Launches New Pre-Surgery Education Program for Bariatric Patients
30/06/2025
Photo: Erdem Hospital via FL Communications ISTANBUL, June 30, 2025 (GLOBE NEWSWIRE) -- Erdem Hospital in Istanbul has announced the launch of a new pre-operative education program tailored specifically for bariatric [...]
EUROAPI cède le site de Haverhill à Particle Dynamics dans le cadre du plan de transformation FOCUS-27
30/06/2025
Communiqué de presse Paris – Le 30 juin 2025 - EUROAPI annonce ce jour la signature d’un accord (Share Purchase Agreement - SPA) portant sur la cession de 100% des titres de EUROAPI UK Ltd, la filiale exploitant son [...]
EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 transformation plan
30/06/2025
Press Release Paris – June 30, 2025 – EUROAPI today announced the signing of a share purchase agreement (SPA) for the sale of 100% of EUROAPI UK Ltd, the subsidiary operating its Haverhill manufacturing site, with a [...]
OSE Immunotherapeutics publie une Lettre aux Actionnaires
30/06/2025
OSE Immunotherapeutics publie une Lettre aux Actionnaires NANTES, France, 30 juin 2025, 18 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce la publication de sa première Lettre aux [...]
OSE Immunotherapeutics Publishes Letter to Shareholders
30/06/2025
OSE Immunotherapeutics Publishes Letter to Shareholders NANTES, France, June 30, 2025, 6:00 p.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), announces the publication of its inaugural Letter to [...]
IBA – Notification de Transparence - Dénominateur
30/06/2025
30 juin 2025 Publication effectuée en vertu de l’article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes dans des émetteurs dont les actions sont admises à la négociation sur un marché [...]
IBA – Transparency Notification - Denominator
30/06/2025
June 30 th , 2025 Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market and containing various [...]
Transactions under Novonesis’ share buyback program
30/06/2025
Novonesis has now completed the announced share buyback program of B shares worth up to EUR 100 million (DKK 746 million) in total during 2025. As of June 27th, 2025, Novonesis has purchased an accumulated 1,729,099 [...]
Baylor Genetics’ Chairman and CEO Kengo Takishima Named One of Houston Business Journal’s 2025 Most Admired CEOs
30/06/2025
Award is one of Houston’s most inspiring celebrations of leadership, where CEOs and visionaries are at the helm of the city’s most successful and impactful organizations HOUSTON, June 30, 2025 (GLOBE NEWSWIRE) -- Baylor [...]
NADP Reports Dental Benefits Market on Road to Recovery
30/06/2025
Market Continues to Rebound from Pandemic Era DALLAS, June 30, 2025 (GLOBE NEWSWIRE) -- The health of the dental benefits industry showed visible signs of recovery at year-end 2023, following market disruptions [...]
AdipoPharma Recognized at American Diabetes Association 85th Annual Meeting for PATAS, Its First-in-Class Whole-Body Insulin-Sensitizing Compound
30/06/2025
CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- AdipoPharma , a biotech company headquartered in France with offices in the U.S. and Belgium, was recognized at the American Diabetes Association’s 85 th Annual Meeting this [...]
More Tests, No Insurance Needed: HNL Lab Medicine Grows Self-Pay Offerings
30/06/2025
ALLENTOWN, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- HNL Lab Medicine is redefining convenience in healthcare with the expansion of its HNL Lab Tests Direct menu, adding dozens of new self-pay tests that empower patients [...]
Biofrontera Inc. Announces Major Restructuring of Relationship With Biofrontera AG Backed By $11 Million Investment
30/06/2025
Biofrontera Inc. has signed an agreement to acquire all US assets related to Ameluz ® and RhodoLED ® including New Drug Application (NDA) and associated patents from Germany-based Biofrontera AG. Under their new [...]
SPR Receives Fourth Consecutive Northeast Ohio Top Workplaces Award
30/06/2025
- Based on employee feedback highlighting strong corporate culture - CLEVELAND, June 30, 2025 (GLOBE NEWSWIRE) -- For the fourth year in a row, SPR has been recognized as a Top Workplace by Northeast Ohio Top Workplaces [...]
Assembly Biosciences Doses First Participant in Phase 1b Portion of Phase 1a/b Clinical Trial of Investigational Long-Acting Herpes Simplex Virus Helicase-Primase Inhibitor ABI-1179
30/06/2025
– Study will evaluate safety and antiviral activity of ABI-1179 in participants with recurrent genital herpes – – ABI-1179 IND cleared to support study expansion to sites in United States – – Phase 1b studies for ABI- [...]
Synergy CHC Corp. (NASDAQ: SNYR) Secures Landmark Retail and Distribution Wins Across North America for FOCUSfactor Supplements and Functional Beverages
30/06/2025
Core-Mark National Authorization, Walmart Canada Breakthrough, and Key Regional Wins Highlight Rapid Growth in Functional Beverage and Supplement Categories WESTBROOK, Maine, June 30, 2025 (GLOBE NEWSWIRE) -- Synergy [...]
IMUNON Submits Plan in Consultation with the Exchange to Ensure Compliance with Nasdaq’s Listing Requirement, Anticipates Additional Compliance Period
30/06/2025
LAWRENCEVILLE, N.J., June 30, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (NASDAQ: IMNN) , a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that, in consultation with The [...]
Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS Regions
30/06/2025
Er-Kim will distribute KIMMTRAK® (tebentafusp) for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma, in accordance with applicable local regulations in the agreed regions [...]
CRISPR Therapeutics Named to TIME’s Most Influential Companies List of 2025
30/06/2025
ZUG, Switzerland and BOSTON, June 30, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, has been named [...]

Pages